GovWire

Decision: Regulatory approval of Spikevax bivalent Original/Omicron booster vaccine

Medicines Healthcare Products Regulatory Agency

November 24
09:04 2022

Summary of Product Characteristics Spikevax bivalent Original/Omicron

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Patient Information Leaflet Spikevax bivalent Original/Omicron

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Spikevax bivalent Original/Omicron Information for Healthcare Professionals (Regulation 174)

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Spikevax bivalent Original/Omicron Patient Information Leaflet (Regulation 174)

This file may not be suitable for users of assistive technology.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: